PMHSOTCPharmaceutical PreparationsUS GAAP · USD

Polomar Health Services, Inc.

Polomar Health Services, Inc. is a U.S.-based pharmaceutical preparations company that appears to operate through product fulfillment, distribution, pharmacy services, and compounding-related agreements. The company’s filings indicate a business built around healthcare product and service delivery arrangements rather than a broad consumer brand portfolio.

Ask about the company
Revenue0.6m USD
+1,002.0 %y/y
Operating profit (EBIT)-10.6m USD
−711.9 %y/y
EBIT margin-1,627.5%
+581.6 ppy/y
Net income-10.7m USD
−697.8 %y/y

Fiscal year 2025 · change from previous year

Development 2022–2025

-12.5-10.0-7.5-5.0-2.50.02.5m USD2022: 0.03 m USD2022: EBIT -0.18 m USD20222023: 0.04 m USD2023: EBIT -0.44 m USD20232024: 0.06 m USD2024: EBIT -1.3 m USD20242025: 0.65 m USD2025: EBIT -11 m USD20250.65-11
RevenueOperating profit (EBIT)

Business

Share of revenue
Product Fulfillment and Distribution45 %

Arrangement-based fulfillment and distribution of healthcare-related products.

Pharmacy Services25 %

Pharmacy service offerings tied to healthcare product delivery and support.

Compounding Services15 %

Custom compounding and related preparation services for healthcare use.

Professional and Administrative Services15 %

Contracted services supporting operations, commercialization, and execution.

Customers

The company’s customers appear to be healthcare and life-science counterparties that need fulfillment, distribution, pharmacy, or compounding support under contract. Its business model suggests revenue is driven by counterparties that value specialized handling, service execution, and reliable supply-chain coordination.

Healthcare product and service partners

Buy fulfillment, distribution, and related support services to move healthcare products through the supply chain.

Pharmacy and compounding customers

Use pharmacy services and compounding capabilities for specialized preparation and dispensing needs.

Contracting counterparties

Enter service and supply agreements that define the company’s operating revenue base.

Strategy

The company’s disclosed agreements point to a strategy centered on building contracted healthcare service relationships across fulfillment, distribution, and pharmacy-related activities. Its competitive position likely depends on execution quality, regulatory compliance, and the ability to support counterparties through specialized service arrangements.

Deepen contracted healthcare service relationshipsShort term

Contracted arrangements provide the operating base and visibility for a small healthcare services platform.

Broaden service scope across fulfillment, pharmacy, and compoundingMedium term

A wider service mix can increase customer stickiness and reduce dependence on any single arrangement.

Geography

Polomar Health Services is organized as a U.S. company, and the available filings do not disclose a meaningful country-by-country revenue split. Based on the disclosed agreements, the business appears centered on domestic operations and U.S.-based counterparties.

Risks

The company appears exposed to contract concentration, execution risk, and regulatory oversight typical of pharmaceutical and pharmacy-related businesses. Because its model depends on third-party agreements and healthcare handling, disruptions in counterparties, compliance, or service performance could materially affect operations.

Sorted by severity
Customer and contract concentrationHigh

The disclosed business is built around specific agreements, so loss or non-renewal of a key contract could reduce activity quickly.

Exposure: Revenue and operating scale

Regulatory and compliance riskHigh

Pharmaceutical preparations, pharmacy services, and compounding are subject to healthcare regulation and oversight.

ExposureLicensingOperationsProduct handling
Execution and service quality riskMedium

Fulfillment and distribution businesses depend on accurate, timely, and compliant execution across the supply chain.

Exposure: Customer retention and liability

Counterparty and financing riskMedium

The filings reference promissory notes and loan agreements, indicating reliance on external funding relationships.

Exposure: Liquidity and covenant-like obligations

Accounting

Judgemental items
Revenue recognition on service contracts

Fulfillment, distribution, and pharmacy agreements may require judgment on when control transfers and when revenue is earned.

Impact: Affects reported revenue timing and comparability across periods

Receivables and credit losses

Contract-based healthcare businesses can build receivables from counterparties, requiring estimation of collectability.

Impact: Affects operating results through bad-debt expense

Debt and related financing disclosures

The company disclosed promissory notes and loan agreements, which require interest, principal, and related-party accounting review.

Impact: Affects leverage presentation and cash flow obligations

Similar listed companies

Publicly listed companies with a comparable business focus.

Palomar Holdings, Inc.

PLMR · Fire, Marine & Casualty Insurance

Zicix Corp

ZICX · Services-Advertising

Pacific Health Care Organization Inc

PFHO · Services-Misc Health & Allied Services, NEC

P3 Health Partners Inc.

PIII · Services-Health Services

Telomir Pharmaceuticals, Inc.

TELO · Pharmaceutical Preparations

Elite Health Systems Inc.

EHSI · Services-Specialty Outpatient Facilities, NEC

Last updated: 24/09/2026